BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 37530299)

  • 1. Lifting the White Walker's curse-Management of Coats' disease.
    Kelkar A; Bolisetty M
    Indian J Ophthalmol; 2023 Aug; 71(8):3117. PubMed ID: 37530299
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Coats' disease: characteristics, management, outcome, and scleral external drainage with anterior chamber maintainer for stage 3b disease.
    Yousef YA; ElRimawi AH; Nazzal RM; Qaroot AF; AlAref AH; Mohammad M; Abureesh O; Rejdak R; Nowomiejska K; Avitabile T; Toro MD; AlNawaiseh I
    Medicine (Baltimore); 2020 Apr; 99(16):e19623. PubMed ID: 32311932
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recent advances in the diagnosis and treatment of Coats' disease.
    Yang X; Wang C; Su G
    Int Ophthalmol; 2019 Apr; 39(4):957-970. PubMed ID: 30895419
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rhegmatogenous retinal detachment in Coats' disease: a case report.
    Khadka S; Byanju R; Parajuli S
    J Med Case Rep; 2021 Dec; 15(1):631. PubMed ID: 34969406
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bevacizumab for Coats' disease with exudative retinal detachment and risk of vitreoretinal traction.
    Ramasubramanian A; Shields CL
    Br J Ophthalmol; 2012 Mar; 96(3):356-9. PubMed ID: 21653215
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk of Tractional Retinal Detachment Following Intravitreal Bevacizumab Along with Subretinal Fluid Drainage and Cryotherapy for Stage 3B Coats' Disease.
    Bhat V; D'Souza P; Shah PK; Narendran V
    Middle East Afr J Ophthalmol; 2016; 23(2):208-11. PubMed ID: 27162454
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Visual outcomes after treatment in pediatric patients with Coats' disease.
    Chiu HH; Wan MJ; Kertes PJ; Muni RH; Lam WC
    Can J Ophthalmol; 2019 Dec; 54(6):647-652. PubMed ID: 31836093
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Adjuvant anti-VEGF therapy in Coats' disease].
    Fiorentzis M; Stavridis E; Seitz B; Viestenz A
    Ophthalmologe; 2015 May; 112(5):451-4. PubMed ID: 25134462
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-Term Outcomes of Total Exudative Retinal Detachments in Stage 3B Coats Disease.
    Li AS; Capone A; Trese MT; Sears JE; Kychenthal A; De la Huerta I; Ferrone PJ
    Ophthalmology; 2018 Jun; 125(6):887-893. PubMed ID: 29361355
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Coats' disease in Tanzania: first case report and literature review.
    Rugwizangoga B; Mwabili T; Scanlan T; Meyer P; Kitinya J
    Afr Health Sci; 2014 Sep; 14(3):763-8. PubMed ID: 25352900
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combination treatment of pediatric coats' disease: a bicenter study in Taiwan.
    Lin CJ; Chen SN; Hwang JF; Yang CM
    J Pediatr Ophthalmol Strabismus; 2013; 50(6):356-62. PubMed ID: 24669373
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Coats' disease of adult-onset in 48 eyes.
    Rishi E; Rishi P; Appukuttan B; Uparkar M; Sharma T; Gopal L
    Indian J Ophthalmol; 2016 Jul; 64(7):518-23. PubMed ID: 27609165
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Integrating Scleral Buckling, Transscleral Drainage of Subretinal Fluid, Intravitreal Anti-Vascular Endothelial Growth Factor, and Laser Photocoagulation in Stage 3B Coats' Total Retinal Detachment.
    Huang YC; Lai CC; Wu WC
    Ophthalmic Surg Lasers Imaging Retina; 2016 Sep; 47(9):865-8. PubMed ID: 27631484
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Associations of cytokine concentrations in aqueous humour with retinal vascular abnormalities and exudation in Coats' disease.
    Zhang J; Jiang C; Ruan L; Huang X
    Acta Ophthalmol; 2019 May; 97(3):319-324. PubMed ID: 30414256
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early onset coats' disease initially treated as unilateral ROP at 39 weeks postmenstrual age: a case report.
    Peng J; Zhang Q; Chen C; Huang Q; Li Y; Zhao P
    BMC Ophthalmol; 2017 Aug; 17(1):145. PubMed ID: 28814287
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selective photocoagulation in Coats' disease: ten-year follow-up.
    Nucci P; Bandello F; Serafino M; Wilson ME
    Eur J Ophthalmol; 2002; 12(6):501-5. PubMed ID: 12510719
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of stage 3 Coats' disease by endolaser photocoagulation via a two-port pars plana nonvitrectomy approach.
    Cai X; Zhao P; Zhang Q; Jin H
    Graefes Arch Clin Exp Ophthalmol; 2015 Jul; 253(7):999-1004. PubMed ID: 25794987
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pars plana vitrectomy for treatment of advanced Coats' disease--presentation of a modified surgical technique and long-term follow-up.
    Suesskind D; Altpeter E; Schrader M; Bartz-Schmidt KU; Aisenbrey S
    Graefes Arch Clin Exp Ophthalmol; 2014 Jun; 252(6):873-9. PubMed ID: 24218042
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Classification of the spectrum of Coats' disease as subtypes of idiopathic retinal telangiectasis with exudation.
    Cahill M; O'Keefe M; Acheson R; Mulvihill A; Wallace D; Mooney D
    Acta Ophthalmol Scand; 2001 Dec; 79(6):596-602. PubMed ID: 11782226
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fluorescein Angiographic Abnormalities in the Contralateral Eye with Normal Fundus in Children with Unilateral Coats' Disease.
    Jung EH; Kim JH; Kim SJ; Yu YS
    Korean J Ophthalmol; 2018 Feb; 32(1):65-69. PubMed ID: 29376220
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.